查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2143488

人用硫酸粘菌素市場：全球市場預測，2026-2032年

Colistin Sulfate for Humans Market - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 197 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，人類硫酸粘菌素市場將成長至 16.294 億美元，複合年成長率為 7.12%。

主要市場統計數據
基準年 2025 9.9021億美元
預計年份：2026年 1,051,480,000 美元
預測年份 2032 16.0294億美元
複合年成長率 (%) 7.12%

硫酸粘菌素是一種多粘菌素類抗生素，用於治療由多重抗藥性革蘭氏陰性菌引起的嚴重感染疾病，但使用範圍有限。其臨床應用受限於其腎毒性、神經毒性、給藥途徑複雜以及存在更安全、更具標靶性的替代藥物。因此，合理使用硫酸粘菌素需要藥物管理、微生物學確認以及專科醫生的監督。

抗生素的合理使用以及抗藥性細菌的出現正在改變抗生素在臨床實踐中的使用方式。

目前，抗生素治療的重點正從依賴廣泛經驗性用藥轉向基於實證醫學證據和藥敏試驗的精準治療。醫院正在加強抗生素的合理使用管理、感染預防、診斷檢測、根據腎功能調整劑量以及治療監測。移動性粘菌素抗藥性機制的出現進一步凸顯了在人類、動物和環境領域進行監測、農業管控和協調一致的公共衛生應對措施的重要性。

人工智慧有助於做出更安全、更基於證據的決策。

人工智慧 (AI) 可透過加速抗藥性模式分析、識別高毒性風險患者、輔助解讀檢測結果以及改善感染控制監測，從而促進粘菌素的合理使用。其價值取決於具有代表性的數據、透明的檢驗、臨床醫生的審查以及與當地治療指南的一致性。人工智慧應「輔助」而非「取代」微生物學判斷、藥理學專業知識和針對特定患者的決策。

六個醫療保健環境的區域洞察

在北美，重點在於藥物管理、監管、先進的診斷技術以及對抗藥性病原體的監測。在歐洲，協調一致的抗藥性監測與藥物使用限制政策和跨境公共衛生合作相結合。亞太地區面臨多重抗藥性感染疾病的沉重負擔，而獲得診斷和專科護理的機會仍然不均等。在拉丁美洲，各方正持續努力加強檢查室能力、採購系統和感染預防。在中東，三級醫療能力正在擴大，同時控制跨國傳播的風險。非洲的優先事項包括確保藥品的可靠供應、加強檢查室建設、監測以及發展感染控制基礎設施。

區域洞察：多邊優先事項和醫療衛生系統協調

東協在跨境監測、檢查室網路建設和協調合理使用抗生素方面尤其重要。金磚國家成員國面臨抗生素抗藥性負擔、醫療衛生系統能力以及對抗抗藥性優先事項等方面的諸多挑戰，因此數據共用和建立具有韌性的供應系統至關重要。歐盟支持協調一致的監測和審慎的抗生素政策。七國集團成員國普遍優先考慮創新、準備和合理使用。海灣合作理事會國家則著重於三級醫療體系、診斷品質和區域協調。北約成員國也同樣關注抗生素儲備、醫療衛生連續性和作戰醫學。

國際觀點：通用的抗菌素抗藥性挑戰下的不同需求

澳洲、加拿大、法國、德國、義大利、日本、韓國、英國、英國和美國普遍建立了適當的用藥控制和監測框架，重點在於減輕罕見和嚴重的抗藥性感染疾病及毒性。巴西、中國、印度、墨西哥和俄羅斯則致力於解決診斷、處方規範、監測覆蓋範圍和感染控制能力的差異。在上述所有國家，合理用藥均依賴當地的藥物敏感性數據、國家指南、藥品品質保證和專家監督。

給領導者的建議：在維持療效的同時，提高病人安全。

製藥業和醫療保健系統的領導者應優先考慮快速藥敏試驗、標準化劑量和腎功能監測方案、臨床教育以及透明的不利事件報告。他們還應協調對人類、動物和環境中的抗菌藥物抗藥性進行監測，增加對感染預防的投入，維護品質保證的供應鏈，並利用具有臨床意義的證據評估新的診斷方法和替代療法。管治應包括審計和回饋機制、對特殊用藥的明確限制以及可衡量的合理用藥結果指標。

調查方法：基於證據的專業治療解讀

本執行摘要採用定性整合框架，重點在於已確立的硫酸粘菌素用於人體的臨床、微生物學、藥理學、監管和公共衛生證據。報告透過分析抗藥性監測、藥物管理成熟度、診斷可及性、感染控制能力和醫療基礎設施方面的差異，解讀了必要的區域、群體和國家特定地理背景。本摘要未使用任何市場規模估算、市場佔有率、預測或公司特定聲明。

結論：硫酸粘菌素的使用需要精準控制、監督和調整。

當針對嚴重多重抗藥性革蘭氏陰性病菌感染的有效治療手段寥寥無幾時，硫酸粘菌素仍是重要的首選治療方案。為了充分發揮其應有的作用，準確診斷、基於藥敏試驗結果的處方、預防毒性反應以及強力的抗藥性監測至關重要。臨床醫生、實驗室、監管機構、醫療衛生系統和公共衛生部門之間的協調努力對於維持效用、保護患者以及遏制抗藥性的進一步發展至關重要。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 市場進入策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：人工智慧的累積影響，2026年

第7章 人用硫酸粘菌素市場：依給藥途徑分類

  • 靜脈
  • 口服

第8章：人用硫酸粘菌素市場：依適應症分類

  • 複雜性尿道感染
  • 院內肺炎
  • 皮膚和軟組織感染疾病

第9章：人類用硫酸粘菌素市場：按劑型分類

  • 注射用粉劑
  • 解決方案

第10章：人用硫酸粘菌素市場：依濃度分類

  • 150,000 IU/mL
  • 250,000 IU/mL

第11章 人用硫酸粘菌素市場：依最終用戶分類

  • 門診部
  • 診所
  • 醫院

第12章：人用硫酸粘菌素市場：依通路分類

  • 醫院藥房
  • 網路藥房
  • 零售藥房
    • 連鎖藥局
    • 獨立藥房

第13章：人用硫酸粘菌素市場：依地區分類

  • 亞太地區
  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 中東
  • 非洲

第14章 人用硫酸粘菌素市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章：人用硫酸粘菌素市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章 競爭格局

  • 2025年市佔率分析
  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年

第17章：公司簡介

  • Aurobindo Pharma Ltd.
  • Cipla Ltd.
  • Dr. Reddy's Laboratories Ltd.
  • Fengchen Group
  • Fresenius Kabi AG
  • Fujian Lifecome Biochemistry Co., Ltd.
  • Hikma Pharmaceuticals PLC
  • JSN Chemicals
  • Livzon Pharmaceutical Group Inc.
  • Lupin Ltd.
  • Mallinckrodt Pharmaceuticals
  • Mylan NV
  • Sandoz International GmbH
  • Shandong Lukang Pharmaceutical Co., Ltd.
  • Shengxue Dacheng Pharmaceutical
  • SNA Health Care
  • Taj Pharmaceuticals Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • Xellia Pharmaceuticals ApS
  • Zhejiang Apeloa Kangyu Pharmaceutical Co., Ltd.

第18章 主要專家

Product Code: MRR-9C4233EE7CFA

The Colistin Sulfate for Humans Market is projected to grow by USD 1,602.94 million at a CAGR of 7.12% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 990.21 million
Estimated Year [2026] USD 1,051.48 million
Forecast Year [2032] USD 1,602.94 million
CAGR (%) 7.12%

Human colistin sulfate is a polymyxin antibiotic used in limited circumstances against serious infections caused by multidrug-resistant Gram-negative bacteria. Its clinical role is constrained by nephrotoxicity, neurotoxicity, dosing complexity, and the availability of safer or more targeted alternatives. Stewardship, microbiological confirmation, and specialist oversight therefore shape appropriate use.

Stewardship and Resistance Are Reshaping Clinical Use

The landscape is shifting from broad empirical reliance toward carefully justified, susceptibility-guided treatment. Hospitals are strengthening antimicrobial stewardship, infection prevention, diagnostic testing, renal-dose adjustment, and therapeutic monitoring. The emergence of mobile colistin-resistance mechanisms has further increased the importance of surveillance, agricultural controls, and coordinated public-health responses across human, animal, and environmental settings.

Artificial Intelligence Supports Safer, Evidence-Based Decisions

Artificial intelligence can contribute to colistin stewardship by accelerating resistance-pattern analysis, identifying patients at elevated toxicity risk, supporting laboratory interpretation, and improving infection-control surveillance. Its value depends on representative data, transparent validation, clinician review, and alignment with local treatment guidelines. AI should support-not replace-microbiological judgment, pharmacological expertise, and patient-specific decision-making.

Regional Insights Across Six Healthcare Environments

North America emphasizes stewardship, regulatory oversight, advanced diagnostics, and monitoring of resistant pathogens. Europe combines coordinated resistance surveillance with restrictive use policies and cross-border public-health collaboration. Asia-Pacific faces substantial resistant-infection burdens alongside varied access to diagnostics and specialist care. Latin America continues to strengthen laboratory capacity, procurement practices, and infection prevention. The Middle East is expanding tertiary-care capabilities while managing cross-border transmission risks. Africa's priorities include reliable medicine access, laboratory strengthening, surveillance, and infection-control infrastructure.

Group Insights: Multilateral Priorities and Health-System Coordination

ASEAN cooperation is particularly relevant to cross-border surveillance, laboratory networking, and harmonized stewardship. BRICS members reflect diverse burdens, health-system capacities, and resistance-control priorities, making data sharing and resilient supply systems important. The European Union supports coordinated surveillance and prudent antimicrobial policies. G7 members generally emphasize innovation, preparedness, and stewardship. GCC countries are focused on tertiary-care capacity, diagnostic quality, and regional coordination. NATO members also have interests in antimicrobial preparedness, continuity of care, and operational medicine.

Country Insights: Different Needs Within a Shared Resistance Challenge

Australia, Canada, France, Germany, Italy, Japan, South Korea, Spain, the United Kingdom, and the United States generally have established stewardship and surveillance frameworks, with attention directed toward rare, severe, resistant infections and toxicity mitigation. Brazil, China, India, Mexico, and Russia are addressing heterogeneous access to diagnostics, prescribing practices, surveillance coverage, and infection-control capacity. Across all listed countries, appropriate use depends on local susceptibility data, national guidance, medicine-quality assurance, and specialist oversight.

Actions for Leaders: Protect Efficacy While Improving Patient Safety

Industry and health-system leaders should prioritize rapid susceptibility testing, standardized dosing and renal-monitoring protocols, clinical education, and transparent adverse-event reporting. They should coordinate human, veterinary, and environmental resistance surveillance; invest in infection prevention; maintain quality-assured supply channels; and evaluate new diagnostics and alternatives using clinically meaningful evidence. Governance should include audit-and-feedback systems, clear restrictions for exceptional use, and measurable stewardship outcomes.

Research Methodology: Evidence-Based Interpretation of a Specialized Therapy

This executive summary applies a qualitative synthesis framework focused on established clinical, microbiological, pharmacological, regulatory, and public-health evidence concerning human colistin sulfate. It interprets the required regional, group, and country geographies through differences in resistance surveillance, stewardship maturity, diagnostic access, infection-control capacity, and healthcare infrastructure. No market estimates, market shares, forecasts, or company-specific claims are used.

Conclusion: Colistin Sulfate Requires Precision, Oversight, and Coordination

Human colistin sulfate remains an important reserve option when severe multidrug-resistant Gram-negative infections leave few effective treatments. Its responsible role depends on precise diagnosis, susceptibility-guided prescribing, toxicity prevention, and robust resistance surveillance. Coordinated action across clinicians, laboratories, regulators, health systems, and public-health authorities is essential to preserve usefulness while protecting patients and limiting further resistance.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. New Revenue Opportunities
  • 3.4. Next-Generation Business Models
  • 3.5. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Colistin Sulfate for Humans Market, by Route Of Administration

  • 7.1. Introduction
  • 7.2. Intravenous
  • 7.3. Oral

8. Colistin Sulfate for Humans Market, by Indication

  • 8.1. Introduction
  • 8.2. Complicated Urinary Tract Infections
  • 8.3. Hospital Acquired Pneumonia
  • 8.4. Skin And Soft Tissue Infections

9. Colistin Sulfate for Humans Market, by Formulation

  • 9.1. Introduction
  • 9.2. Powder For Injection
  • 9.3. Solution

10. Colistin Sulfate for Humans Market, by Strength

  • 10.1. Introduction
  • 10.2. 150000 Iu/Ml
  • 10.3. 250000 Iu/Ml

11. Colistin Sulfate for Humans Market, by End User

  • 11.1. Introduction
  • 11.2. Ambulatory Care Centers
  • 11.3. Clinics
  • 11.4. Hospitals

12. Colistin Sulfate for Humans Market, by Distribution Channel

  • 12.1. Introduction
  • 12.2. Hospital Pharmacies
  • 12.3. Online Pharmacies
  • 12.4. Retail Pharmacies
    • 12.4.1. Chain Pharmacies
    • 12.4.2. Independent Pharmacies

13. Colistin Sulfate for Humans Market, by Region

  • 13.1. Introduction
  • 13.2. Asia-Pacific
  • 13.3. North America
  • 13.4. Latin America
  • 13.5. Europe
  • 13.6. Middle East
  • 13.7. Africa

14. Colistin Sulfate for Humans Market, by Group

  • 14.1. Introduction
  • 14.2. ASEAN
  • 14.3. GCC
  • 14.4. European Union
  • 14.5. BRICS
  • 14.6. G7
  • 14.7. NATO

15. Colistin Sulfate for Humans Market, by Country

  • 15.1. Introduction
  • 15.2. United States
  • 15.3. Canada
  • 15.4. Mexico
  • 15.5. Brazil
  • 15.6. United Kingdom
  • 15.7. Germany
  • 15.8. France
  • 15.9. Russia
  • 15.10. Italy
  • 15.11. Spain
  • 15.12. China
  • 15.13. India
  • 15.14. Japan
  • 15.15. Australia
  • 15.16. South Korea

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2025
  • 16.2. Market Concentration Analysis, 2025
    • 16.2.1. Concentration Ratio (CR)
    • 16.2.2. Herfindahl Hirschman Index (HHI)
  • 16.3. Recent Developments & Impact Analysis, 2025
  • 16.4. Product Portfolio Analysis, 2025
  • 16.5. Benchmarking Analysis, 2025

17. Company Profiles

  • 17.1. Aurobindo Pharma Ltd.
  • 17.2. Cipla Ltd.
  • 17.3. Dr. Reddy's Laboratories Ltd.
  • 17.4. Fengchen Group
  • 17.5. Fresenius Kabi AG
  • 17.6. Fujian Lifecome Biochemistry Co., Ltd.
  • 17.7. Hikma Pharmaceuticals PLC
  • 17.8. JSN Chemicals
  • 17.9. Livzon Pharmaceutical Group Inc.
  • 17.10. Lupin Ltd.
  • 17.11. Mallinckrodt Pharmaceuticals
  • 17.12. Mylan N.V.
  • 17.13. Sandoz International GmbH
  • 17.14. Shandong Lukang Pharmaceutical Co., Ltd.
  • 17.15. Shengxue Dacheng Pharmaceutical
  • 17.16. SNA Health Care
  • 17.17. Taj Pharmaceuticals Ltd.
  • 17.18. Teva Pharmaceutical Industries Ltd.
  • 17.19. Xellia Pharmaceuticals ApS
  • 17.20. Zhejiang Apeloa Kangyu Pharmaceutical Co., Ltd.

18. Key Experts

LIST OF FIGURES

  • FIGURE 1. Global Colistin Sulfate for Humans Market, Years Considered for the Study
  • FIGURE 2. Global Colistin Sulfate for Humans Market, Research Design
  • FIGURE 3. Global Colistin Sulfate for Humans Market, Research Framework
  • FIGURE 4. Global Colistin Sulfate for Humans Market, Data Triangulation
  • FIGURE 5. Global Colistin Sulfate for Humans Market Size, 2017-2032 (USD Million)
  • FIGURE 6. Global Colistin Sulfate for Humans Market Size, by Route Of Administration, 2025 vs 2032 (%)
  • FIGURE 7. Global Colistin Sulfate for Humans Market Size, by Route Of Administration, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 8. Global Colistin Sulfate for Humans Market Size, by Indication, 2025 vs 2032 (%)
  • FIGURE 9. Global Colistin Sulfate for Humans Market Size, by Indication, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 10. Global Colistin Sulfate for Humans Market Size, by Formulation, 2025 vs 2032 (%)
  • FIGURE 11. Global Colistin Sulfate for Humans Market Size, by Formulation, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 12. Global Colistin Sulfate for Humans Market Size, by Strength, 2025 vs 2032 (%)
  • FIGURE 13. Global Colistin Sulfate for Humans Market Size, by Strength, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 14. Global Colistin Sulfate for Humans Market Size, by End User, 2025 vs 2032 (%)
  • FIGURE 15. Global Colistin Sulfate for Humans Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 16. Global Colistin Sulfate for Humans Market Size, by Distribution Channel, 2025 vs 2032 (%)
  • FIGURE 17. Global Colistin Sulfate for Humans Market Size, by Distribution Channel, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 18. Global Colistin Sulfate for Humans Market Size, by Region, 2025 vs 2032 (%)
  • FIGURE 19. Global Colistin Sulfate for Humans Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 20. Global Colistin Sulfate for Humans Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 21. Global Colistin Sulfate for Humans Market Size, by Country, 2025 vs 2032 (%)
  • FIGURE 22. Global Colistin Sulfate for Humans Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 23. Global Colistin Sulfate for Humans Market Share, by Key Player, 2025

LIST OF TABLES

  • TABLE 1. Global Colistin Sulfate for Humans Market Segmentation & Coverage
  • TABLE 2. Global Colistin Sulfate for Humans Market Size, 2017-2032 (USD Million)
  • TABLE 3. Global Colistin Sulfate for Humans Market Size, by Route Of Administration, 2017-2032 (USD Million)
  • TABLE 4. Global Intravenous Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 5. Global Intravenous Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 6. Global Intravenous Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 7. Global Oral Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 8. Global Oral Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 9. Global Oral Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 10. Global Colistin Sulfate for Humans Market Size, by Indication, 2017-2032 (USD Million)
  • TABLE 11. Global Complicated Urinary Tract Infections Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 12. Global Complicated Urinary Tract Infections Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 13. Global Complicated Urinary Tract Infections Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 14. Global Hospital Acquired Pneumonia Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 15. Global Hospital Acquired Pneumonia Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 16. Global Hospital Acquired Pneumonia Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 17. Global Skin And Soft Tissue Infections Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 18. Global Skin And Soft Tissue Infections Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 19. Global Skin And Soft Tissue Infections Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 20. Global Colistin Sulfate for Humans Market Size, by Formulation, 2017-2032 (USD Million)
  • TABLE 21. Global Powder For Injection Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 22. Global Powder For Injection Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 23. Global Powder For Injection Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 24. Global Solution Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 25. Global Solution Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 26. Global Solution Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 27. Global Colistin Sulfate for Humans Market Size, by Strength, 2017-2032 (USD Million)
  • TABLE 28. Global 150000 Iu/Ml Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 29. Global 150000 Iu/Ml Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 30. Global 150000 Iu/Ml Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 31. Global 250000 Iu/Ml Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 32. Global 250000 Iu/Ml Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 33. Global 250000 Iu/Ml Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 34. Global Colistin Sulfate for Humans Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 35. Global Ambulatory Care Centers Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 36. Global Ambulatory Care Centers Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 37. Global Ambulatory Care Centers Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 38. Global Clinics Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 39. Global Clinics Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 40. Global Clinics Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 41. Global Hospitals Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 42. Global Hospitals Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 43. Global Hospitals Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 44. Global Colistin Sulfate for Humans Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 45. Global Hospital Pharmacies Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 46. Global Hospital Pharmacies Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 47. Global Hospital Pharmacies Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 48. Global Online Pharmacies Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 49. Global Online Pharmacies Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 50. Global Online Pharmacies Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 51. Global Retail Pharmacies Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 52. Global Retail Pharmacies Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 53. Global Retail Pharmacies Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 54. Global Chain Pharmacies Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 55. Global Chain Pharmacies Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 56. Global Chain Pharmacies Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 57. Global Independent Pharmacies Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 58. Global Independent Pharmacies Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 59. Global Independent Pharmacies Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 60. Global Colistin Sulfate for Humans Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 61. Asia-Pacific Colistin Sulfate for Humans Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 62. Asia-Pacific Colistin Sulfate for Humans Market Size, by Route Of Administration, 2017-2032 (USD Million)
  • TABLE 63. Asia-Pacific Colistin Sulfate for Humans Market Size, by Indication, 2017-2032 (USD Million)
  • TABLE 64. Asia-Pacific Colistin Sulfate for Humans Market Size, by Formulation, 2017-2032 (USD Million)
  • TABLE 65. Asia-Pacific Colistin Sulfate for Humans Market Size, by Strength, 2017-2032 (USD Million)
  • TABLE 66. Asia-Pacific Colistin Sulfate for Humans Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 67. Asia-Pacific Colistin Sulfate for Humans Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 68. Asia-Pacific Colistin Sulfate for Humans Market Size, by Retail Pharmacies, 2017-2032 (USD Million)
  • TABLE 69. North America Colistin Sulfate for Humans Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 70. North America Colistin Sulfate for Humans Market Size, by Route Of Administration, 2017-2032 (USD Million)
  • TABLE 71. North America Colistin Sulfate for Humans Market Size, by Indication, 2017-2032 (USD Million)
  • TABLE 72. North America Colistin Sulfate for Humans Market Size, by Formulation, 2017-2032 (USD Million)
  • TABLE 73. North America Colistin Sulfate for Humans Market Size, by Strength, 2017-2032 (USD Million)
  • TABLE 74. North America Colistin Sulfate for Humans Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 75. North America Colistin Sulfate for Humans Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 76. North America Colistin Sulfate for Humans Market Size, by Retail Pharmacies, 2017-2032 (USD Million)
  • TABLE 77. Latin America Colistin Sulfate for Humans Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 78. Latin America Colistin Sulfate for Humans Market Size, by Route Of Administration, 2017-2032 (USD Million)
  • TABLE 79. Latin America Colistin Sulfate for Humans Market Size, by Indication, 2017-2032 (USD Million)
  • TABLE 80. Latin America Colistin Sulfate for Humans Market Size, by Formulation, 2017-2032 (USD Million)
  • TABLE 81. Latin America Colistin Sulfate for Humans Market Size, by Strength, 2017-2032 (USD Million)
  • TABLE 82. Latin America Colistin Sulfate for Humans Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 83. Latin America Colistin Sulfate for Humans Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 84. Latin America Colistin Sulfate for Humans Market Size, by Retail Pharmacies, 2017-2032 (USD Million)
  • TABLE 85. Europe Colistin Sulfate for Humans Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 86. Europe Colistin Sulfate for Humans Market Size, by Route Of Administration, 2017-2032 (USD Million)
  • TABLE 87. Europe Colistin Sulfate for Humans Market Size, by Indication, 2017-2032 (USD Million)
  • TABLE 88. Europe Colistin Sulfate for Humans Market Size, by Formulation, 2017-2032 (USD Million)
  • TABLE 89. Europe Colistin Sulfate for Humans Market Size, by Strength, 2017-2032 (USD Million)
  • TABLE 90. Europe Colistin Sulfate for Humans Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 91. Europe Colistin Sulfate for Humans Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 92. Europe Colistin Sulfate for Humans Market Size, by Retail Pharmacies, 2017-2032 (USD Million)
  • TABLE 93. Middle East Colistin Sulfate for Humans Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 94. Middle East Colistin Sulfate for Humans Market Size, by Route Of Administration, 2017-2032 (USD Million)
  • TABLE 95. Middle East Colistin Sulfate for Humans Market Size, by Indication, 2017-2032 (USD Million)
  • TABLE 96. Middle East Colistin Sulfate for Humans Market Size, by Formulation, 2017-2032 (USD Million)
  • TABLE 97. Middle East Colistin Sulfate for Humans Market Size, by Strength, 2017-2032 (USD Million)
  • TABLE 98. Middle East Colistin Sulfate for Humans Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 99. Middle East Colistin Sulfate for Humans Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 100. Middle East Colistin Sulfate for Humans Market Size, by Retail Pharmacies, 2017-2032 (USD Million)
  • TABLE 101. Africa Colistin Sulfate for Humans Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 102. Africa Colistin Sulfate for Humans Market Size, by Route Of Administration, 2017-2032 (USD Million)
  • TABLE 103. Africa Colistin Sulfate for Humans Market Size, by Indication, 2017-2032 (USD Million)
  • TABLE 104. Africa Colistin Sulfate for Humans Market Size, by Formulation, 2017-2032 (USD Million)
  • TABLE 105. Africa Colistin Sulfate for Humans Market Size, by Strength, 2017-2032 (USD Million)
  • TABLE 106. Africa Colistin Sulfate for Humans Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 107. Africa Colistin Sulfate for Humans Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 108. Africa Colistin Sulfate for Humans Market Size, by Retail Pharmacies, 2017-2032 (USD Million)
  • TABLE 109. Global Colistin Sulfate for Humans Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 110. ASEAN Colistin Sulfate for Humans Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 111. ASEAN Colistin Sulfate for Humans Market Size, by Route Of Administration, 2017-2032 (USD Million)
  • TABLE 112. ASEAN Colistin Sulfate for Humans Market Size, by Indication, 2017-2032 (USD Million)
  • TABLE 113. ASEAN Colistin Sulfate for Humans Market Size, by Formulation, 2017-2032 (USD Million)
  • TABLE 114. ASEAN Colistin Sulfate for Humans Market Size, by Strength, 2017-2032 (USD Million)
  • TABLE 115. ASEAN Colistin Sulfate for Humans Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 116. ASEAN Colistin Sulfate for Humans Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 117. ASEAN Colistin Sulfate for Humans Market Size, by Retail Pharmacies, 2017-2032 (USD Million)
  • TABLE 118. GCC Colistin Sulfate for Humans Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 119. GCC Colistin Sulfate for Humans Market Size, by Route Of Administration, 2017-2032 (USD Million)
  • TABLE 120. GCC Colistin Sulfate for Humans Market Size, by Indication, 2017-2032 (USD Million)
  • TABLE 121. GCC Colistin Sulfate for Humans Market Size, by Formulation, 2017-2032 (USD Million)
  • TABLE 122. GCC Colistin Sulfate for Humans Market Size, by Strength, 2017-2032 (USD Million)
  • TABLE 123. GCC Colistin Sulfate for Humans Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 124. GCC Colistin Sulfate for Humans Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 125. GCC Colistin Sulfate for Humans Market Size, by Retail Pharmacies, 2017-2032 (USD Million)
  • TABLE 126. European Union Colistin Sulfate for Humans Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 127. European Union Colistin Sulfate for Humans Market Size, by Route Of Administration, 2017-2032 (USD Million)
  • TABLE 128. European Union Colistin Sulfate for Humans Market Size, by Indication, 2017-2032 (USD Million)
  • TABLE 129. European Union Colistin Sulfate for Humans Market Size, by Formulation, 2017-2032 (USD Million)
  • TABLE 130. European Union Colistin Sulfate for Humans Market Size, by Strength, 2017-2032 (USD Million)
  • TABLE 131. European Union Colistin Sulfate for Humans Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 132. European Union Colistin Sulfate for Humans Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 133. European Union Colistin Sulfate for Humans Market Size, by Retail Pharmacies, 2017-2032 (USD Million)
  • TABLE 134. BRICS Colistin Sulfate for Humans Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 135. BRICS Colistin Sulfate for Humans Market Size, by Route Of Administration, 2017-2032 (USD Million)
  • TABLE 136. BRICS Colistin Sulfate for Humans Market Size, by Indication, 2017-2032 (USD Million)
  • TABLE 137. BRICS Colistin Sulfate for Humans Market Size, by Formulation, 2017-2032 (USD Million)
  • TABLE 138. BRICS Colistin Sulfate for Humans Market Size, by Strength, 2017-2032 (USD Million)
  • TABLE 139. BRICS Colistin Sulfate for Humans Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 140. BRICS Colistin Sulfate for Humans Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 141. BRICS Colistin Sulfate for Humans Market Size, by Retail Pharmacies, 2017-2032 (USD Million)
  • TABLE 142. G7 Colistin Sulfate for Humans Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 143. G7 Colistin Sulfate for Humans Market Size, by Route Of Administration, 2017-2032 (USD Million)
  • TABLE 144. G7 Colistin Sulfate for Humans Market Size, by Indication, 2017-2032 (USD Million)
  • TABLE 145. G7 Colistin Sulfate for Humans Market Size, by Formulation, 2017-2032 (USD Million)
  • TABLE 146. G7 Colistin Sulfate for Humans Market Size, by Strength, 2017-2032 (USD Million)
  • TABLE 147. G7 Colistin Sulfate for Humans Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 148. G7 Colistin Sulfate for Humans Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 149. G7 Colistin Sulfate for Humans Market Size, by Retail Pharmacies, 2017-2032 (USD Million)
  • TABLE 150. NATO Colistin Sulfate for Humans Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 151. NATO Colistin Sulfate for Humans Market Size, by Route Of Administration, 2017-2032 (USD Million)
  • TABLE 152. NATO Colistin Sulfate for Humans Market Size, by Indication, 2017-2032 (USD Million)
  • TABLE 153. NATO Colistin Sulfate for Humans Market Size, by Formulation, 2017-2032 (USD Million)
  • TABLE 154. NATO Colistin Sulfate for Humans Market Size, by Strength, 2017-2032 (USD Million)
  • TABLE 155. NATO Colistin Sulfate for Humans Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 156. NATO Colistin Sulfate for Humans Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 157. NATO Colistin Sulfate for Humans Market Size, by Retail Pharmacies, 2017-2032 (USD Million)
  • TABLE 158. Global Colistin Sulfate for Humans Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 159. United States Colistin Sulfate for Humans Market Size, 2017-2032 (USD Million)
  • TABLE 160. United States Colistin Sulfate for Humans Market Size, by Route Of Administration, 2017-2032 (USD Million)
  • TABLE 161. United States Colistin Sulfate for Humans Market Size, by Indication, 2017-2032 (USD Million)
  • TABLE 162. United States Colistin Sulfate for Humans Market Size, by Formulation, 2017-2032 (USD Million)
  • TABLE 163. United States Colistin Sulfate for Humans Market Size, by Strength, 2017-2032 (USD Million)
  • TABLE 164. United States Colistin Sulfate for Humans Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 165. United States Colistin Sulfate for Humans Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 166. United States Colistin Sulfate for Humans Market Size, by Retail Pharmacies, 2017-2032 (USD Million)
  • TABLE 167. Canada Colistin Sulfate for Humans Market Size, 2017-2032 (USD Million)
  • TABLE 168. Canada Colistin Sulfate for Humans Market Size, by Route Of Administration, 2017-2032 (USD Million)
  • TABLE 169. Canada Colistin Sulfate for Humans Market Size, by Indication, 2017-2032 (USD Million)
  • TABLE 170. Canada Colistin Sulfate for Humans Market Size, by Formulation, 2017-2032 (USD Million)
  • TABLE 171. Canada Colistin Sulfate for Humans Market Size, by Strength, 2017-2032 (USD Million)
  • TABLE 172. Canada Colistin Sulfate for Humans Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 173. Canada Colistin Sulfate for Humans Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 174. Canada Colistin Sulfate for Humans Market Size, by Retail Pharmacies, 2017-2032 (USD Million)
  • TABLE 175. Mexico Colistin Sulfate for Humans Market Size, 2017-2032 (USD Million)
  • TABLE 176. Mexico Colistin Sulfate for Humans Market Size, by Route Of Administration, 2017-2032 (USD Million)
  • TABLE 177. Mexico Colistin Sulfate for Humans Market Size, by Indication, 2017-2032 (USD Million)
  • TABLE 178. Mexico Colistin Sulfate for Humans Market Size, by Formulation, 2017-2032 (USD Million)
  • TABLE 179. Mexico Colistin Sulfate for Humans Market Size, by Strength, 2017-2032 (USD Million)
  • TABLE 180. Mexico Colistin Sulfate for Humans Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 181. Mexico Colistin Sulfate for Humans Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 182. Mexico Colistin Sulfate for Humans Market Size, by Retail Pharmacies, 2017-2032 (USD Million)
  • TABLE 183. Brazil Colistin Sulfate for Humans Market Size, 2017-2032 (USD Million)
  • TABLE 184. Brazil Colistin Sulfate for Humans Market Size, by Route Of Administration, 2017-2032 (USD Million)
  • TABLE 185. Brazil Colistin Sulfate for Humans Market Size, by Indication, 2017-2032 (USD Million)
  • TABLE 186. Brazil Colistin Sulfate for Humans Market Size, by Formulation, 2017-2032 (USD Million)
  • TABLE 187. Brazil Colistin Sulfate for Humans Market Size, by Strength, 2017-2032 (USD Million)
  • TABLE 188. Brazil Colistin Sulfate for Humans Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 189. Brazil Colistin Sulfate for Humans Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 190. Brazil Colistin Sulfate for Humans Market Size, by Retail Pharmacies, 2017-2032 (USD Million)
  • TABLE 191. United Kingdom Colistin Sulfate for Humans Market Size, 2017-2032 (USD Million)
  • TABLE 192. United Kingdom Colistin Sulfate for Humans Market Size, by Route Of Administration, 2017-2032 (USD Million)
  • TABLE 193. United Kingdom Colistin Sulfate for Humans Market Size, by Indication, 2017-2032 (USD Million)
  • TABLE 194. United Kingdom Colistin Sulfate for Humans Market Size, by Formulation, 2017-2032 (USD Million)
  • TABLE 195. United Kingdom Colistin Sulfate for Humans Market Size, by Strength, 2017-2032 (USD Million)
  • TABLE 196. United Kingdom Colistin Sulfate for Humans Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 197. United Kingdom Colistin Sulfate for Humans Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 198. United Kingdom Colistin Sulfate for Humans Market Size, by Retail Pharmacies, 2017-2032 (USD Million)
  • TABLE 199. Germany Colistin Sulfate for Humans Market Size, 2017-2032 (USD Million)
  • TABLE 200. Germany Colistin Sulfate for Humans Market Size, by Route Of Administration, 2017-2032 (USD Million)
  • TABLE 201. Germany Colistin Sulfate for Humans Market Size, by Indication, 2017-2032 (USD Million)
  • TABLE 202. Germany Colistin Sulfate for Humans Market Size, by Formulation, 2017-2032 (USD Million)
  • TABLE 203. Germany Colistin Sulfate for Humans Market Size, by Strength, 2017-2032 (USD Million)
  • TABLE 204. Germany Colistin Sulfate for Humans Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 205. Germany Colistin Sulfate for Humans Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 206. Germany Colistin Sulfate for Humans Market Size, by Retail Pharmacies, 2017-2032 (USD Million)
  • TABLE 207. France Colistin Sulfate for Humans Market Size, 2017-2032 (USD Million)
  • TABLE 208. France Colistin Sulfate for Humans Market Size, by Route Of Administration, 2017-2032 (USD Million)
  • TABLE 209. France Colistin Sulfate for Humans Market Size, by Indication, 2017-2032 (USD Million)
  • TABLE 210. France Colistin Sulfate for Humans Market Size, by Formulation, 2017-2032 (USD Million)
  • TABLE 211. France Colistin Sulfate for Humans Market Size, by Strength, 2017-2032 (USD Million)
  • TABLE 212. France Colistin Sulfate for Humans Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 213. France Colistin Sulfate for Humans Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 214. France Colistin Sulfate for Humans Market Size, by Retail Pharmacies, 2017-2032 (USD Million)
  • TABLE 215. Russia Colistin Sulfate for Humans Market Size, 2017-2032 (USD Million)
  • TABLE 216. Russia Colistin Sulfate for Humans Market Size, by Route Of Administration, 2017-2032 (USD Million)
  • TABLE 217. Russia Colistin Sulfate for Humans Market Size, by Indication, 2017-2032 (USD Million)
  • TABLE 218. Russia Colistin Sulfate for Humans Market Size, by Formulation, 2017-2032 (USD Million)
  • TABLE 219. Russia Colistin Sulfate for Humans Market Size, by Strength, 2017-2032 (USD Million)
  • TABLE 220. Russia Colistin Sulfate for Humans Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 221. Russia Colistin Sulfate for Humans Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 222. Russia Colistin Sulfate for Humans Market Size, by Retail Pharmacies, 2017-2032 (USD Million)
  • TABLE 223. Italy Colistin Sulfate for Humans Market Size, 2017-2032 (USD Million)
  • TABLE 224. Italy Colistin Sulfate for Humans Market Size, by Route Of Administration, 2017-2032 (USD Million)
  • TABLE 225. Italy Colistin Sulfate for Humans Market Size, by Indication, 2017-2032 (USD Million)
  • TABLE 226. Italy Colistin Sulfate for Humans Market Size, by Formulation, 2017-2032 (USD Million)
  • TABLE 227. Italy Colistin Sulfate for Humans Market Size, by Strength, 2017-2032 (USD Million)
  • TABLE 228. Italy Colistin Sulfate for Humans Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 229. Italy Colistin Sulfate for Humans Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 230. Italy Colistin Sulfate for Humans Market Size, by Retail Pharmacies, 2017-2032 (USD Million)
  • TABLE 231. Spain Colistin Sulfate for Humans Market Size, 2017-2032 (USD Million)
  • TABLE 232. Spain Colistin Sulfate for Humans Market Size, by Route Of Administration, 2017-2032 (USD Million)
  • TABLE 233. Spain Colistin Sulfate for Humans Market Size, by Indication, 2017-2032 (USD Million)
  • TABLE 234. Spain Colistin Sulfate for Humans Market Size, by Formulation, 2017-2032 (USD Million)
  • TABLE 235. Spain Colistin Sulfate for Humans Market Size, by Strength, 2017-2032 (USD Million)
  • TABLE 236. Spain Colistin Sulfate for Humans Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 237. Spain Colistin Sulfate for Humans Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 238. Spain Colistin Sulfate for Humans Market Size, by Retail Pharmacies, 2017-2032 (USD Million)
  • TABLE 239. China Colistin Sulfate for Humans Market Size, 2017-2032 (USD Million)
  • TABLE 240. China Colistin Sulfate for Humans Market Size, by Route Of Administration, 2017-2032 (USD Million)
  • TABLE 241. China Colistin Sulfate for Humans Market Size, by Indication, 2017-2032 (USD Million)
  • TABLE 242. China Colistin Sulfate for Humans Market Size, by Formulation, 2017-2032 (USD Million)
  • TABLE 243. China Colistin Sulfate for Humans Market Size, by Strength, 2017-2032 (USD Million)
  • TABLE 244. China Colistin Sulfate for Humans Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 245. China Colistin Sulfate for Humans Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 246. China Colistin Sulfate for Humans Market Size, by Retail Pharmacies, 2017-2032 (USD Million)
  • TABLE 247. India Colistin Sulfate for Humans Market Size, 2017-2032 (USD Million)
  • TABLE 248. India Colistin Sulfate for Humans Market Size, by Route Of Administration, 2017-2032 (USD Million)
  • TABLE 249. India Colistin Sulfate for Humans Market Size, by Indication, 2017-2032 (USD Million)
  • TABLE 250. India Colistin Sulfate for Humans Market Size, by Formulation, 2017-2032 (USD Million)
  • TABLE 251. India Colistin Sulfate for Humans Market Size, by Strength, 2017-2032 (USD Million)
  • TABLE 252. India Colistin Sulfate for Humans Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 253. India Colistin Sulfate for Humans Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 254. India Colistin Sulfate for Humans Market Size, by Retail Pharmacies, 2017-2032 (USD Million)
  • TABLE 255. Japan Colistin Sulfate for Humans Market Size, 2017-2032 (USD Million)
  • TABLE 256. Japan Colistin Sulfate for Humans Market Size, by Route Of Administration, 2017-2032 (USD Million)
  • TABLE 257. Japan Colistin Sulfate for Humans Market Size, by Indication, 2017-2032 (USD Million)
  • TABLE 258. Japan Colistin Sulfate for Humans Market Size, by Formulation, 2017-2032 (USD Million)
  • TABLE 259. Japan Colistin Sulfate for Humans Market Size, by Strength, 2017-2032 (USD Million)
  • TABLE 260. Japan Colistin Sulfate for Humans Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 261. Japan Colistin Sulfate for Humans Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 262. Japan Colistin Sulfate for Humans Market Size, by Retail Pharmacies, 2017-2032 (USD Million)
  • TABLE 263. Australia Colistin Sulfate for Humans Market Size, 2017-2032 (USD Million)
  • TABLE 264. Australia Colistin Sulfate for Humans Market Size, by Route Of Administration, 2017-2032 (USD Million)
  • TABLE 265. Australia Colistin Sulfate for Humans Market Size, by Indication, 2017-2032 (USD Million)
  • TABLE 266. Australia Colistin Sulfate for Humans Market Size, by Formulation, 2017-2032 (USD Million)
  • TABLE 267. Australia Colistin Sulfate for Humans Market Size, by Strength, 2017-2032 (USD Million)
  • TABLE 268. Australia Colistin Sulfate for Humans Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 269. Australia Colistin Sulfate for Humans Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 270. Australia Colistin Sulfate for Humans Market Size, by Retail Pharmacies, 2017-2032 (USD Million)
  • TABLE 271. South Korea Colistin Sulfate for Humans Market Size, 2017-2032 (USD Million)
  • TABLE 272. South Korea Colistin Sulfate for Humans Market Size, by Route Of Administration, 2017-2032 (USD Million)
  • TABLE 273. South Korea Colistin Sulfate for Humans Market Size, by Indication, 2017-2032 (USD Million)
  • TABLE 274. South Korea Colistin Sulfate for Humans Market Size, by Formulation, 2017-2032 (USD Million)
  • TABLE 275. South Korea Colistin Sulfate for Humans Market Size, by Strength, 2017-2032 (USD Million)
  • TABLE 276. South Korea Colistin Sulfate for Humans Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 277. South Korea Colistin Sulfate for Humans Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 278. South Korea Colistin Sulfate for Humans Market Size, by Retail Pharmacies, 2017-2032 (USD Million)
  • TABLE 279. Global Colistin Sulfate for Humans Market Share, by Key Player, 2025
  • TABLE 280. Global Colistin Sulfate for Humans Market, Key Experts